Relay Therapeutics CFO Thomas Catinazzo sells common shares worth $540,157.67
RLAY•Relay Therapeutics CFO Thomas Catinazzo sold 32,717 common shares at $16.51 per share on Nov. 18, 2026. His direct beneficial ownership totaled 70,948 shares after the sale.
1. Share sale
Chief Financial Officer Thomas Catinazzo sold 32,717 Relay Therapeutics common shares at $16.51 per share on Nov. 18, 2026. His direct beneficial ownership totaled 70,948 common shares following the transaction.




